TREOSULFAN- VERSUS BUSULFAN-BASED CONDITIONING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME: A SINGLE-CENTRE RETROSPECTIVE PROPENSITY SCORE-MATCHED COHORT STUDY

被引：0
|
作者：
Moya, Tommy Alfaro [1 ,2 ]
Remberger, Mats [3 ]
Chen, Carol [1 ]
Gerbitz, Armin [1 ,2 ]
Kim, Dennis Dong Hwan [1 ,2 ]
Kumar, Rajat [1 ,2 ]
Lam, Wilson [1 ,2 ]
Law, Arjun Datt [1 ,2 ]
Lipton, Jeffrey H. [1 ,2 ]
Michelis, Fotios V. [1 ,2 ]
Basso, Igor Novitzky [1 ,2 ]
Viswabandya, Auro [1 ,2 ]
Mattsson, Jonas [1 ,2 ]
Pasic, Ivan [1 ,2 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Uppsala Hosp, Uppsala, Sweden
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O060
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [31] Treosulfan Based Preparative Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Thalassemia Major: Report of Two Pediatric Cases From a Single-Centre
    Eker, I.
    Gursel, O.
    Babacan, O.
    Kurekci, A. E.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5589 - 5589
  • [32] Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6-Year Propensity Score-Matched Cohort Study
    Zhou, Jifang
    Han, Jin
    Nutescu, Edith A.
    Pate, Pritesh R.
    Sweiss, Karen
    Calip, Gregory S.
    PHARMACOTHERAPY, 2019, 39 (01): : 55 - 66
  • [33] Allogeneic Hematopoietic Stem-Cell Transplantation Using Fludarabine/Treosulfan Conditioning Regimen Compared with Busulfan-Based Myeloablative and Reduced-Intensity Conditioning in Patients with AML and Mds; Relative Outcomes Depend On Disease Status at Transplantation
    Shimoni, Avichai
    Rand, Avital
    Shem-Tov, Noga
    Hardan, Izhar
    Volchek, Yulia
    Maayaan, Hannah
    Yerushalmi, Ronit
    Nagler, Arnon
    BLOOD, 2009, 114 (22) : 1303 - 1304
  • [34] Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis
    Itonaga, Hidehiro
    Kida, Michiko
    Hamamura, Atsushi
    Uchida, Naoyuki
    Ozawa, Yukiyasu
    Fukuda, Takahiro
    Ueda, Yasunori
    Kataoka, Keisuke
    Katayama, Yuta
    Ota, Shuichi
    Matsuoka, Ken-ichi
    Kondo, Tadakazu
    Eto, Tetsuya
    Kanda, Junya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Miyazaki, Yasushi
    Ishiyama, Ken
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 752 - 762
  • [35] Thiotepa-treosulfan-fludarabine (ttf) as conditioning regimen in patients undergoing allogeneic hematopoietic stem cell transplantation (allohsct) for myelofibrosis or myelodysplastic syndrome: A single center experience
    Canale, F. A.
    Porto, G.
    Provenzano, P. F.
    Naso, V.
    Moscato, T.
    Pugliese, M.
    Loteta, B.
    Irrera, G.
    Console, G.
    Ferreri, A.
    Martino, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 236 - 236
  • [36] Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis
    Song, Ga-Young
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Jin Seok
    Min, Chang-Ki
    Kim, Kihyun
    Choi, Yunsuk
    Eom, Hyeon-Seok
    Joo, Young Don
    Kim, Sung-Hyun
    Kwak, Jae-Yong
    Kang, Hye Jin
    Lee, Jae Hoon
    Lee, Ho Sup
    Mun, Yeung-Chul
    Moon, Joon Ho
    Sohn, Sang Kyun
    Park, Seong Kyu
    Park, Yong
    Shin, Ho-Jin
    Yoon, Sung-Soo
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2714 - 2721
  • [37] Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
    Malagola, Michele
    Polverelli, Nicola
    Martino, Massimo
    Patriarca, Francesca
    Bruno, Benedetto
    Giaccone, Luisa
    Grillo, Giovanni
    Bramanti, Stefania
    Bernasconi, Paolo
    De Gobbi, Marco
    Natale, Annalisa
    Terruzzi, Elisabetta
    Olivieri, Attilio
    Chiusolo, Patrizia
    Carella, Angelo Michele
    Casini, Marco
    Maffini, Enrico
    Nozzoli, Chiara
    Mazza, Patrizio
    Bassi, Simona
    Onida, Francesco
    Vacca, Adriana
    Falcioni, Sadia
    Luppi, Mario
    Iori, Anna Paola
    Pavone, Vincenzo
    Skert, Cristina
    Carluccio, Paola
    Borghero, Carlo
    Proia, Anna
    Selleri, Carmine
    Rubini, Vicky
    Sacchi, Nicoletta
    Oldani, Elena
    Bonifazi, Francesca
    Ciceri, Fabio
    Russo, Domenico
    TRANSPLANTATION DIRECT, 2023, 9 (03): : E1451
  • [38] Retrospective single-centre study of patients with refractory Hodgkin's lymphoma: allogeneic stem cell transplantation compared to conventional treatment using the propensity score matching method
    Labussiere, H.
    Rigon, M. Resche
    Brice, P.
    Ribaud, P.
    Devergie, A.
    Petropoulou, A.
    De Latour, R. Peffault
    Socie, G.
    Robin, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S250 - S250
  • [39] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (SCT) USING FLUDARABINE/TREOSULFAN CONDITIONING REGIMEN COMPARED WITH BUSULFAN-BASED MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING IN PATIENTS WITH AML AND MDS; RELATIVE OUTCOMES DEPEND ON DISEASE STATUS AT SCT
    Shimoni, A.
    Shem-Tov, N.
    Rand, A.
    Volchek, Y.
    Yerushalmi, R.
    Hardan, I
    Nagler, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S231 - S231
  • [40] OUTCOMES OF UPFRONT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION AND IMMUNOSUPPRESSIVE THERAPY FOR ADULT WITH SEVERE APLASTIC ANEMIA: A MULTICENTER RETROSPECTIVE AND PROPENSITY SCORE-MATCHED STUDY
    Wu, Liangliang
    Zhao, Xin
    Liu, Limin
    Zhang, Yuping
    Wu, Depei
    Zhang, Fengkui
    Wang, Shunqing
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 338 - 339
12345